Heterogeneity of meningeal B cells reveals a lymphopoietic niche at the CNS borders
Author(s) -
Simone Brioschi,
Wei-Le Wang,
Vincent Peng,
Meng Wang,
Irina Shchukina,
Zev J. Greenberg,
Jennifer K. Bando,
Natália Jaeger,
Rafael S. Czepielewski,
Amanda Swain,
Denis A. Mogilenko,
Wandy L. Beatty,
Peter O. Bayguinov,
James A. J. Fitzpatrick,
Laura G. Schuettpelz,
Catrina C. Fronick,
Igor Smirnov,
Jonathan Kipnis,
Virginia Smith Shapiro,
Gregory F. Wu,
Susan Gilfillan,
Marina Cella,
Maxim N. Artyomov,
Steven H. Kleinstein,
Marco Colonna
Publication year - 2021
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.abf9277
Subject(s) - niche , biology , neuroscience , ecology
Getting around the blood–brain barrier The meninges comprise three membranes that surround and protect the central nervous system (CNS). Recent studies have noted the existence of myeloid cells resident there, but little is known about their ontogeny and function, and whether other meningeal immune cell populations have important roles remains unclear (see the Perspective by Nguyen and Kubes). Cugurraet al. found in mice that a large proportion of continuously replenished myeloid cells in the dura mater are not blood derived, but rather transit from cranial bone marrow through specialized channels. In models of CNS injury and neuroinflammation, the authors demonstrated that these myeloid cells have an immunoregulatory phenotype compared with their more inflammatory blood-derived counterparts. Similarly, Brioschiet al. show that the meninges host B cells that are also derived from skull bone marrow, mature locally, and likely acquire a tolerogenic phenotype. They further found that the brains of aging mice are infiltrated by a second population of age-associated B cells, which come from the periphery and may differentiate into autoantibody-secreting plasma cells after encountering CNS antigens. Together, these two studies may inform future treatment of neurological diseases.Science , abf7844, abf9277, this issue p.eabf7844 , p.eabf9277 ; see also abj8183, p.396
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom